CDSCO approves Covishield, COVAXIN for restricted emergency use in India


Tribune News Service
New Delhi, January 3

Central Drugs Standard Control Organisation(CDSCO) on Sunday approved Covishield and COVAXIN for restricted emergency use in India.

India’s COVID-19 tally of cases climbed to 1,03,23,965 with 18,177 new cases in a day, while 99,27,310 people have recuperated so far pushing the national recovery rate to 96.15 per cent on Sunday, according to the Union Health Ministry data.



Be the first to comment on "CDSCO approves Covishield, COVAXIN for restricted emergency use in India"

Leave a comment

Your email address will not be published.


*


%d bloggers like this: